Trial · NCT02597907
Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant
NCT02597907, Not applicable, Completed, Kyungpook National University Hospital; results first posted 2017-04-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant. Trials, record NCT02597907. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02597907
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant
- NCT number
- NCT02597907
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 88 participants, actual
- Lead sponsor
- Kyungpook National University Hospital
- Conditions
- Postoperative Nausea and Vomiting
- Interventions
- aprepitant, palonosetron, Ramosetron
- First posted
- 2015-11-05
- Last updated
- 2017-04-25
- Results first posted
- 2017-04-25
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Incidence of Postoperative Nausea and Vomiting | 24 hours | The incidence of postoperative nausea and vomiting during 24 hours postoperatively |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Incidence of Postoperative Nausea and Vomiting | 24 hours | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Incidence of Postoperative Nausea and Vomiting | Aprepitant Plus Palonosetron | 5 | Participants | ||
| The Incidence of Postoperative Nausea and Vomiting | Aprepitant Plus Ramosetron | 18 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Aprepitant Plus Ramosetron | 44 | |
| Overall Study | STARTED | Aprepitant Plus Palonosetron | 44 | |
| Overall Study | COMPLETED | Aprepitant Plus Ramosetron | 44 | |
| Overall Study | COMPLETED | Aprepitant Plus Palonosetron | 44 | |
| Overall Study | NOT COMPLETED | Aprepitant Plus Ramosetron | 0 | |
| Overall Study | NOT COMPLETED | Aprepitant Plus Palonosetron | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Aprepitant Plus Palonosetron | 0 | 44 |
| Total, all-cause mortality | Aprepitant Plus Ramosetron | 0 | 44 |
| Total, other adverse events | Aprepitant Plus Palonosetron | 0 | 44 |
| Total, other adverse events | Aprepitant Plus Ramosetron | 0 | 44 |
| Total, serious adverse events | Aprepitant Plus Palonosetron | 0 | 44 |
| Total, serious adverse events | Aprepitant Plus Ramosetron | 0 | 44 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Aprepitant Plus Palonosetron vs Aprepitant Plus Ramosetron: The Incidence of Postoperative Nausea and Vomiting | Trial comparisons |
| Aprepitant Plus Palonosetron vs Aprepitant Plus Ramosetron: deaths from any cause | Trial comparisons |
| Aprepitant Plus Palonosetron vs Aprepitant Plus Ramosetron: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02597907
GET https://conductscience.org/api/trials/v1/NCT02597907/registered